Volume 18 - Issue 12 - December 2005
Editor's Perspective »
Despite the increased awareness of diabetes in recent years and its potentially devastating complications, the recent report from the Centers for Disease Control and Prevention (CDC) offers a grim portrait of the effort to curtail and prevent the condition. In the last two years alone, there has been a 14 percent increase in the prevalence of diabetes in the United States (see page 8, “News And Trends”).
The estimated number of Americans with diabetes now stands at 20.8 million people in the United States, a 2.6 million increase from 2003. The CDC es
Two years ago, I finished a 10-year period as a member of my state podiatric medical licensing board. During that period, I frequently wondered what a podiatrist must feel when he or she receives a registered letter with a notification of a complaint to the board.
Complaints against DPMs came from a variety of sources. Most were from disgruntled patients. Some came from other DPMs, especially when a partnership between two podiatrists breaks up. Some came from the board of pharmacy when a DPM was perceived to be over-prescribing narcotics or possibly Via
News and Trends »
The prevalence of diabetes in the United States has increased by 14 percent in the last two years, according to a recent report by the Centers for Disease Control and Prevention (CDC). The report concludes that 20.8 million people in the U.S., 7 percent of the population, have the disease and 6.2 million of these people are undiagnosed. In 2003, an estimated 18.2 million people had diabetes, according to the CDC.
Why the rapid rise in diabetes prevalence in just two years? The overall incidence of diabetes may be increasing due to declining diets and sed
Diabetes Watch »
Many exciting antibiotics have either recently been approved, received a new FDA indication or will soon become available. Some are well known and have already been incorporated into clinical practice. Many are the first in their respective classes and have novel mechanisms of action. What place, if any, do these drugs have in the treatment of diabetic foot infections (DFIs)?
That said, let us take a look at a number of newer as well as time-tested antibiotics and assess their efficacy for DFIs.
• Linezolid (Zyvox, Pfizer) and q
Practice Builders »
Any practice goes through a number of stages. The “going into practice stage” begins when you make the decision to start your own practice and ends when your cash flow exceeds your expenses, and you begin to take home a paycheck that covers your living expenses.
The third stage is the mature stage where the practice is utilizing between 80 and 100 percent of the time available for patient treatment, and the patient wait for an appointment is longer than two weeks.
In between those two stages is the second stage, the growth stage.
Orthotics Q&A »
Given the nuances of making adjustments to orthotic prescriptions, our expert panelists discuss their approaches in using adjustments such as first ray cutouts and metatarsal pads, and the tools necessary for making modifications. They also discuss which adjustments they will make themselves and which ones they will send out to an orthotics lab. Without further delay, here is what they had to say.
Q: How do you incorporate footwear when determining appropriate orthotic prescriptions?
A: Ideally, Howard Horowitz, DPM, says one s
- « Previous
- | Page 1 of 3 |
- Next »